ORGANIC
LETTERS
2007
Vol. 9, No. 2
327-330
Total Synthesis of Bistramide A
Jason T. Lowe, Iwona E. Wrona, and James S. Panek*
Department of Chemistry and Center for Chemical Methodology and Library
DeVelopment, Metcalf Center for Science and Engineering, Boston UniVersity,
590 Commonwealth AVenue, Boston, Massachusetts 02215
Received December 6, 2006
ABSTRACT
An asymmetric synthesis of the marine metabolite bistramide A is reported. The synthesis relies on the utility of three different organosilane
reagents to construct all principle fragments and 8 of the 11 stereogenic centers of the natural product.
Bistramide A (1) is a marine metabolite initially isolated in
1988 from Lissoclinum bistratum Sluiter near New Cale-
donia.1 Four additional members of the bistramide family
(bistramides B-D and K) have been identified since this
initial report.2 These compounds have been shown to exhibit
numerous biological properties, including antiproliferative,3
antiparasitic,4 immunomodulatory,5 neurotoxic,3 and cyto-
toxic activities.2 Bistramide A was further implicated in a
unique protein kinase Cδ-activation.6 However, recent studies
indicate actin as the primary cell receptor of the natural
product.7
The structure of bistramide A was originally proposed to
be a 19-membered macrocyclic lactam.8 Extensive 2D NMR
analysis,9 however, revealed an acylic compound containing
a substituted tetrahydropyran and spiroketal subunit, con-
nected by a central γ-amino acid linker. Further NMR
analysis10 and chiroptical measurements11 of other members
of the bistramide family (B-D) allowed for the accurate
prediction of the absolute stereochemistry of 1. Kozmin’s
total synthesis of bistramide A12 then confirmed the predicted
stereochemistry and structure as illustrated in Figure 1.
Subsequent to Kozmin’s report, an additional synthesis of
bistramide A13 and one of structurally related bistramide C14
(1) Gouiffe`s, D.; Moreau, S.; Helbecque, N.; Bernier, J. L.; He´nichart,
J. P.; Barbin, Y.; Laurent, D.; Verbist, J. F. Tetrahedron 1988, 44, 451.
(2) Biard, J. F.; Roussakis, C.; Kornprobst, J. M.; Gouiffes-Barbin, D.;
Verbist, J. F.; Cotelle, P.; Foster, M. P.; Ireland, C. M.; Debitus, C. J. Nat.
Prod. 1994, 7, 1336.
(3) Riou, D.; Roussakis, C.; Robillard, N.; Biard, J. F.; Verbist, J. F.
Biol. Cell 1993, 77, 261.
(8) Degnan, B. M.; Hawkins, C. J.; Lavin, M. F.; McCaffrey, E. J.; Parry,
D. L.; Watters, D. J. J. Med. Chem. 1989, 32, 1354.
(9) Foster, M. P.; Mayne, C. L.; Dunkel, R.; Pugmire, R. J.; Grant, D.
M.; Kornprobst, J. M.; Verbist, J. F.; Biard, J. F.; Ireland, C. M. J. Am.
Chem. Soc. 1992, 114, 1110.
(4) Gautret, P.; Le Pape, P.; Biard, J. F.; Menard, D.; Verbist, J. F.;
Marjolet, M. Acta Parasitol. 1998, 43, 50.
(5) Pusset, J.; Maillere, B.; Debitus, C. J. Nat. Toxins 1996, 5, 1.
(6) Griffiths, G.; Garrone, B.; Deacon, E.; Owen, P.; Pongracz, J.; Mead,
G.; Bradwell, A.; Watters, D.; Lord, J. Biochem. Biophys. Res. Commun.
1996, 222, 802.
(10) (a) Gallagher, P. O.; McErlean, C. S. P.; Jacobs, M. F.; Watters, D.
J.; Kitching, W. Tetrahedron Lett. 2002, 43, 531. (b) Solladie´, G.; Baudet,
C.; Biard, J.-F. Tetrahedron Lett. 2000, 41, 7747.
(11) (a) Wipf, P.; Uto, Y.; Yoshimura, S. Chem.-Eur. J. 2002, 8, 1670.
(b) Zuber, G.; Goldsmith, M.-R.; Hopkins, T. D.; Beratan, D. N.; Wipf, P.
Org. Lett. 2005, 7, 5269.
(7) (a) Statsuk, A. V.; Bai, R.; Baryza, J. L.; Verma, V. A.; Hamel, E.;
Wender, P. A.; Kozmin, S. A. Nat. Chem. Biol. 2005, 1, 383. (b) Rizvi, S.
A.; Tereshko, V.; Kossiakoff, A. A.; Kozmin, S. A. J. Am. Chem. Soc.
2006, 128, 3882.
(12) Statsuk, A. V.; Liu, D.; Kozmin, S. A. J. Am. Chem. Soc. 2004,
126, 9546.
(13) Crimmins, M. T.; DeBaillie, A. C. J. Am. Chem. Soc. 2006, 128,
4936.
10.1021/ol062957y CCC: $37.00
© 2007 American Chemical Society
Published on Web 12/23/2006